secwatch / observer
8-K filed May 20, 2026, 5:30 PM ET ticker TMCI CIK 0001630627
other confidence high sentiment neutral materiality 0.10

Treace Medical shareholders elect directors, approve exec compensation and auditor ratification

TREACE MEDICAL CONCEPTS, INC.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TREACE MEDICAL CONCEPTS, INC. shareholders approved Election of three Class II directors at the 2026-05-19 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-05-19
Exact text from the filing
The stockholders elected, by the votes indicated below, the following nominees to the Company’s Board of Directors to serve as Class II directors for a three-year term of office expiring at the 2029 annual meeting of stockholders or until their respective successors have been duly elected and qualified: Name For Withheld Broker Non-Vote Lance A. Berry 33,804,407 820,723 13,516,432 Elizabeth S. Hanna 30,856,965 3,768,165 13,516,432 Jane E. Kiernan 33,587,226 1,037,904 13,516,432
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TREACE MEDICAL CONCEPTS, INC. shareholders approved Advisory vote on executive compensation at the 2026-05-19 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2026-05-19
Exact text from the filing
By the vote stated below, the stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers: For Against Abstain Broker Non-Vote 32,785,505 1,724,383 115,242 13,516,432
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TREACE MEDICAL CONCEPTS, INC. shareholders approved Ratification of appointment of Grant Thornton LLP as independent registered public accounting firm at the 2026-05-19 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-05-19
Exact text from the filing
By the vote stated below, the stockholders ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstain Broker Non-Vote 47,885,305 120,733 135,524 0
View on SEC.gov

Browse all shareholder votes →

TREACE MEDICAL CONCEPTS, INC. filing history →

Source: SEC EDGAR
accession 0001630627-26-000014
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.